Insider Transactions last 24 months for Johnson & Johnson - NYSE: JNJ
Transactions
All
Buy
Sell
Option Exercise
Filer's Name
Relationship/
Trans.
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Total Shares Owned
Taubert Jennifer L EVP, WWC. Innovative Medicine 09/04/2025 DS Direct COM 56,471 $177.81 $10,040,882.63 178,013 Taubert Jennifer L EVP, WWC. Innovative Medicine 09/04/2025 AM Direct COM 56,471 $101.87 $5,752,700.77 234,484 Forminard Elizabeth Executive VP, General Counsel 08/29/2025 DF Direct COM 9,570 $177.20 $1,695,804.00 12,853 Forminard Elizabeth Executive VP, General Counsel 08/29/2025 AM Direct COM 11,521 $115.67 $1,332,634.07 22,423 Duato Joaquin CEO and Chairman of the Board 08/22/2025 DS Direct COM 125,824 $179.21 $22,548,654.81 275,967 Duato Joaquin CEO and Chairman of the Board 08/22/2025 AM Direct COM 125,824 $101.87 $12,817,690.88 401,791 Wolk Joseph J Exec VP, CFO 08/15/2025 DS Direct COM 16,820 $176.91 $2,975,570.69 14,000 Wolk Joseph J Exec VP, CFO 08/15/2025 AM Direct COM 16,820 $101.87 $1,713,453.40 30,820 Reed John C EVP, Innovative Medicine, R&D 07/17/2025 DS Direct COM 19,137 $163.55 $3,129,829.56 10,658 Reed John C EVP, Innovative Medicine, R&D 05/01/2025 DF Direct COM 11,002 $156.31 $1,719,722.62 29,795 Reed John C EVP, Innovative Medicine, R&D 05/01/2025 AM Direct COM 25,255 $0.00 $0.00 40,797 Duato Joaquin CEO and Chairman of the Board 03/18/2025 AG Indirect COM 130,852 $0.00 $0.00 130,852 Duato Joaquin CEO and Chairman of the Board 03/18/2025 DG Direct COM 130,852 $0.00 $0.00 275,967 Decker Robert J VP Corporate Controller 02/25/2025 DS Direct COM 6,999 $165.88 $1,160,994.12 21,001 Decker Robert J VP Corporate Controller 02/25/2025 AM Direct COM 6,999 $101.87 $712,988.13 28,000 Broadhurst Vanessa EVP, Global Corp Affairs 02/18/2025 DF Direct COM 158 $156.15 $24,671.70 21,681 Decker Robert J VP Corporate Controller 02/18/2025 DF Direct COM 94 $156.15 $14,678.10 20,022 Duato Joaquin CEO and Chairman of the Board 02/18/2025 DF Direct COM 1,602 $156.15 $250,152.30 395,923 Forminard Elizabeth Executive VP, General Counsel 02/18/2025 DF Direct COM 307 $156.15 $47,938.05 10,014 Mulholland Kristen EVP, Chief HR Officer 02/18/2025 DF Direct COM 120 $156.15 $18,738.00 12,975 Swanson James D. EVP, CIO 02/18/2025 DF Direct COM 141 $156.15 $22,017.15 16,621 Taubert Jennifer L EVP, WWC. Innovative Medicine 02/18/2025 DF Direct COM 651 $156.15 $101,653.65 170,459 Reed John C EVP, Innovative Medicine, R&D 02/18/2025 DF Direct COM 385 $156.15 $60,117.75 15,542 Wolk Joseph J Exec VP, CFO 02/18/2025 DF Direct COM 768 $156.15 $119,923.20 5,345 Wengel Kathryn E EVP, Chief TO and Risk Officer 02/18/2025 DF Direct COM 200 $156.15 $31,230.00 90,837
1 2 3 4 5 6 7 8 Next Last You are at page 1 of 8 pages
Filer's Name
Relationship/
Trans.
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Total Shares Owned
Duato Joaquin CEO and Chairman of the Board 03/18/2025 AG Indirect COM 130,852 $0.00 $0.00 130,852 Weinberger Mark A Director 12/12/2024 AP Direct COM 1,000 $147.22 $147,220.00 1,000 Wolk Joseph J Exec VP, CFO 10/17/2024 AG Indirect COM 68,835 $0.00 $0.00 68,835 Broadhurst Vanessa EVP, Global Corp Affairs 02/12/2024 AA Direct COM 790 $0.00 $0.00 25,871
1 You are at page 1 of 1 pages
Filer's Name
Relationship/
Trans.
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Total Shares Owned
Taubert Jennifer L EVP, WWC. Innovative Medicine 09/04/2025 DS Direct COM 56,471 $177.81 $10,040,882.63 178,013 Forminard Elizabeth Executive VP, General Counsel 08/29/2025 DF Direct COM 9,570 $177.20 $1,695,804.00 12,853 Duato Joaquin CEO and Chairman of the Board 08/22/2025 DS Direct COM 125,824 $179.21 $22,548,654.81 275,967 Wolk Joseph J Exec VP, CFO 08/15/2025 DS Direct COM 16,820 $176.91 $2,975,570.69 14,000 Reed John C EVP, Innovative Medicine, R&D 07/17/2025 DS Direct COM 19,137 $163.55 $3,129,829.56 10,658 Reed John C EVP, Innovative Medicine, R&D 05/01/2025 DF Direct COM 11,002 $156.31 $1,719,722.62 29,795 Duato Joaquin CEO and Chairman of the Board 03/18/2025 DG Direct COM 130,852 $0.00 $0.00 275,967 Decker Robert J VP Corporate Controller 02/25/2025 DS Direct COM 6,999 $165.88 $1,160,994.12 21,001 Broadhurst Vanessa EVP, Global Corp Affairs 02/18/2025 DF Direct COM 158 $156.15 $24,671.70 21,681 Decker Robert J VP Corporate Controller 02/18/2025 DF Direct COM 94 $156.15 $14,678.10 20,022 Duato Joaquin CEO and Chairman of the Board 02/18/2025 DF Direct COM 1,602 $156.15 $250,152.30 395,923 Forminard Elizabeth Executive VP, General Counsel 02/18/2025 DF Direct COM 307 $156.15 $47,938.05 10,014 Mulholland Kristen EVP, Chief HR Officer 02/18/2025 DF Direct COM 120 $156.15 $18,738.00 12,975 Swanson James D. EVP, CIO 02/18/2025 DF Direct COM 141 $156.15 $22,017.15 16,621 Taubert Jennifer L EVP, WWC. Innovative Medicine 02/18/2025 DF Direct COM 651 $156.15 $101,653.65 170,459 Reed John C EVP, Innovative Medicine, R&D 02/18/2025 DF Direct COM 385 $156.15 $60,117.75 15,542 Wolk Joseph J Exec VP, CFO 02/18/2025 DF Direct COM 768 $156.15 $119,923.20 5,345 Wengel Kathryn E EVP, Chief TO and Risk Officer 02/18/2025 DF Direct COM 200 $156.15 $31,230.00 90,837 Schmid Timothy EVP, WW Chair, MedTech 02/18/2025 DS Direct COM 403 $156.15 $62,928.45 15,098 Broadhurst Vanessa EVP, Global Corp Affairs 02/14/2025 DF Direct COM 997 $156.71 $156,239.87 23,594 Broadhurst Vanessa EVP, Global Corp Affairs 02/14/2025 DF Direct COM 574 $156.71 $89,951.54 21,347 Broadhurst Vanessa EVP, Global Corp Affairs 02/14/2025 DF Direct COM 151 $155.26 $23,444.26 20,091 Decker Robert J VP Corporate Controller 02/14/2025 DF Direct COM 372 $156.71 $58,296.12 21,001 Decker Robert J VP Corporate Controller 02/14/2025 DF Direct COM 254 $156.71 $39,804.34 19,777 Decker Robert J VP Corporate Controller 02/14/2025 DF Direct COM 104 $155.26 $16,147.04 19,181
1 2 3 4 Next Last You are at page 1 of 4 pages
Filer's Name
Relationship/
Trans.
Trans. Type
Ownership Type
Security Type
Shares
Price
Trans.
Total Shares Owned
Taubert Jennifer L EVP, WWC. Innovative Medicine 09/04/2025 AM Direct COM 56,471 $101.87 $5,752,700.77 234,484 Forminard Elizabeth Executive VP, General Counsel 08/29/2025 AM Direct COM 11,521 $115.67 $1,332,634.07 22,423 Duato Joaquin CEO and Chairman of the Board 08/22/2025 AM Direct COM 125,824 $101.87 $12,817,690.88 401,791 Wolk Joseph J Exec VP, CFO 08/15/2025 AM Direct COM 16,820 $101.87 $1,713,453.40 30,820 Reed John C EVP, Innovative Medicine, R&D 05/01/2025 AM Direct COM 25,255 $0.00 $0.00 40,797 Decker Robert J VP Corporate Controller 02/25/2025 AM Direct COM 6,999 $101.87 $712,988.13 28,000 Broadhurst Vanessa EVP, Global Corp Affairs 02/15/2025 AM Direct COM 492 $0.00 $0.00 21,839 Decker Robert J VP Corporate Controller 02/15/2025 AM Direct COM 339 $0.00 $0.00 20,116 Duato Joaquin CEO and Chairman of the Board 02/15/2025 AM Direct COM 3,682 $0.00 $0.00 397,525 Forminard Elizabeth Executive VP, General Counsel 02/15/2025 AM Direct COM 961 $0.00 $0.00 10,321 Mulholland Kristen EVP, Chief HR Officer 02/15/2025 AM Direct COM 419 $0.00 $0.00 13,095 Swanson James D. EVP, CIO 02/15/2025 AM Direct COM 492 $0.00 $0.00 16,762 Taubert Jennifer L EVP, WWC. Innovative Medicine 02/15/2025 AM Direct COM 1,594 $0.00 $0.00 171,110 Reed John C EVP, Innovative Medicine, R&D 02/15/2025 AM Direct COM 1,350 $0.00 $0.00 15,927 Wolk Joseph J Exec VP, CFO 02/15/2025 AM Direct COM 1,971 $0.00 $0.00 6,113 Wengel Kathryn E EVP, Chief TO and Risk Officer 02/15/2025 AM Direct COM 607 $0.00 $0.00 91,037 Schmid Timothy EVP, WW Chair, MedTech 02/15/2025 AM Direct COM 1,029 $0.00 $0.00 15,501 Broadhurst Vanessa EVP, Global Corp Affairs 02/14/2025 AM Direct COM 2,910 $0.00 $0.00 24,591 Broadhurst Vanessa EVP, Global Corp Affairs 02/14/2025 AM Direct COM 1,830 $0.00 $0.00 21,921 Decker Robert J VP Corporate Controller 02/14/2025 AM Direct COM 1,351 $0.00 $0.00 21,373 Decker Robert J VP Corporate Controller 02/14/2025 AM Direct COM 850 $0.00 $0.00 20,031 Duato Joaquin CEO and Chairman of the Board 02/14/2025 AM Direct COM 19,282 $0.00 $0.00 415,205 Duato Joaquin CEO and Chairman of the Board 02/14/2025 AM Direct COM 5,053 $0.00 $0.00 396,041 Forminard Elizabeth Executive VP, General Counsel 02/14/2025 AM Direct COM 1,352 $0.00 $0.00 11,366 Forminard Elizabeth Executive VP, General Counsel 02/14/2025 AM Direct COM 851 $0.00 $0.00 9,627
1 2 3 4 Next Last You are at page 1 of 4 pages
Transaction Type Key A = Acquired, D = Disposed A = Grant, award or other acquisition pursuant to Rule 16b-3(d)
C = Conversion of derivative security |
D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E = Expiration of short derivative position |
F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. |
G = Gift |
H = Expiration (or cancellation) of long derivative position with value received |
I = Discretionary transaction in accordance with Rule 16b-3(f) |
J = Other |
L = Small acquisition under Rule 16a-6 |
M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O = Exercise of out-of-the-money derivative security |
P = Open market or private purchase |
S = Open market or private sale |
U = Disposition pursuant to a tender of shares in a change of control transaction |
W = Acquisition or disposition by will or the laws of descent and distribution |
X = Exercise of in-the-money or at-the-money derivative security |
Z = Deposit into or withdrawal from voting trust
Send to Excel
